P-2055. Modelling the Relative Vaccine Effectiveness of ARCT-154 versus BNT162b2 in Younger and Older Adults
Sign Up to like & getrecommendations! Published in 2025 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofae631.2211
Abstract: Abstract Background While vaccines have proved a key tool in protection from COVID-19, the duration of immunity induced by first-generation mRNA vaccines is limited. Self-amplifying mRNA (SA-mRNA) vaccines have clinically shown to both elicit higher… read more here.
Keywords: arct 154; csl; seqirus usa; stocks bonds ... See more keywords